Literature DB >> 15966184

Clinicopathological analysis of cystic duct carcinoma.

Kun-Ming Chan1, Ta-Sen Yeh, Jeng-Hwei Tseng, Nai-Jen Liu, Yi-Yin Jan, Miin-Fu Chen.   

Abstract

BACKGROUND/AIMS: Gallbladder carcinoma is the most common malignancy of the biliary tract, while the clinical features of cystic duct carcinoma remain unexplored.
METHODOLOGY: Clinicopathological data of 8 cases of cystic duct carcinoma were retrospectively analyzed.
RESULTS: The sample included 5 men and 3 women, with a mean age of 66+/-10 years (range, 49-79 years). Clinical manifestations included jaundice (n=6) and/or abdominal pain (n=6). Two of the patients presented as acute cholecystitis. Preoperative work-ups included ultrasonography (n=8), computed tomography (n=7), and endoscopic retrograde cholangiography (n=6)/or magnetic resonance cholangiography (n=2). Meanwhile, the preoperative diagnoses included cystic duct neoplasms (n=3), common hepatic duct neoplasms (n=4), and gallstones with acute cholecystitis (n=1). Radical procedures, including cholecystectomy, resection of extrahepatic bile duct, and lymph node dissection, were performed in six patients, while palliative cholecystectomy was performed in the remaining two. Notably, five of eight cases displayed lymph node metastasis along the hepaticoduodenal ligament. Median survival was 15 months (range, 6 to 26 months). Two cases with no lymph node metastasis were alive and disease free at 23 months and 26 months, respectively.
CONCLUSIONS: Cystic duct carcinoma is rare. Neoplasm of the cystic duct should be suspected in patients presenting with cystic duct obstruction accompanied by distended nonfunctioning gallbladder without evidence of stone impaction in the cystic duct. The prognosis of cystic duct carcinoma remains dismal. However, for those patients in whom tumors are detected in early stage, curative radical resections possibly provide the chance of potential curable.

Entities:  

Mesh:

Year:  2005        PMID: 15966184

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

1.  Endoscopic biliary imaging and clinicopathological features of cystic duct cancer.

Authors:  Takashi Obana; Naotaka Fujita; Yutaka Noda; Go Kobayashi; Kei Ito; Toshiki Sugawara; Jun Horaguchi; Osamu Takasawa; Takuro Endo; Kazunari Nakahara; Takashi Sawai; Miwa Uzuki; Mika Watanabe
Journal:  J Gastroenterol       Date:  2008-02-29       Impact factor: 7.527

2.  Thirteen-year disease-free survival after surgery for cystic duct carcinoma: a case report.

Authors:  Zine Abedine Benchellal; Kountélé Gona Soro; Isabelle Orain; Hélène Poret; Abd Hak Ferhi; Julien Darquies-Chevalley
Journal:  Case Rep Gastroenterol       Date:  2008-11-14

3.  Remnant cystic duct adenocarcinoma presenting as gastric outlet obstruction.

Authors:  Samuel Tsoon Wuan Lo; Yue Cheng; Frances Cheung; Chung Ngai Tang
Journal:  J Surg Case Rep       Date:  2016-05-06

Review 4.  Primary carcinoma of the cystic duct: a case report and review of classifications.

Authors:  Lovenish Bains; Daljit Kaur; Arun Kumar Kakar; Aman Batish; Seema Rao
Journal:  World J Surg Oncol       Date:  2017-01-19       Impact factor: 2.754

5.  Cystic duct cancer: Should it be deemed as a type of gallbladder cancer?

Authors:  Tu-Nan Yu; Ying-Ying Mao; Fang-Qiang Wei; Hui Liu
Journal:  World J Gastroenterol       Date:  2019-11-28       Impact factor: 5.742

6.  Adenocarcinoma developed from remnant cystic duct after cholecystectomy.

Authors:  Jae Hyuk Do; Yoo Shin Choi; Eun Young Ze
Journal:  BMC Gastroenterol       Date:  2014-10-06       Impact factor: 3.067

7.  Cystic Duct Carcinoma: A New Classification System and the Clinicopathological Features of 62 Patients.

Authors:  Lingxi Nan; Changcheng Wang; Yajie Dai; Jie Wang; Xiaobo Bo; Shulong Zhang; Dexiang Zhang; Houbao Liu; Yueqi Wang
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.